NCT06093100View on ClinicalTrials.gov

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim

RecruitingOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

July 10, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions

Duchenne Muscular Dystrophy

Interventions

DEVICE

wearable technology

Three wearable devices

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors

lead

Vanderbilt University Medical Center

OTHER